DDM News 124.56 09/08/2014 04:41:20 Ultra DOW 30 Proshares (

New Post Public Reply Private Reply Replies (0) Message Board

Sep 8, 2014 at 5:41 AM

Ultra DOW 30 Proshares (DDM) 124.56 $DDM

4 Ways to Play the Dow You Might Never Have Thought Of
Dan Caplinger, The Motley Fool - Motley Fool - Sun Feb 16, 8:01AM CST
More ordinary people follow the Dow Jones Industrials than any other market benchmark, and so it's only natural for beginning investors to tie their investment results to the venerable stock market measure. But rather than just buying all 30 of...

Watch for ProShares Ultra Dow30 to Potentially Pullback After Gaining 1.53% Yesterday
Comtex SmarTrend(R) - Thu Dec 26, 4:40PM CST
ProShares Ultra Dow30 (AMEX

DM) traded in a range yesterday that spanned from a low of $112.68 to a high of $113.86. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $112.21 on volume of 218,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of ProShares Ultra Dow30 to Potentially Pullback after Yesterday's 1.53% Rise
Comtex SmarTrend(R) - Thu Dec 26, 4:39PM CST
ProShares Ultra Dow30 (AMEX

DM) traded in a range yesterday that spanned from a low of $112.68 to a high of $113.86. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $112.21 on volume of 218,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 1.53% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Dec 26, 4:39PM CST
ProShares Ultra Dow30 (AMEX

DM) traded in a range yesterday that spanned from a low of $112.68 to a high of $113.86. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $112.21 on volume of 218,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

AZC, ICE, FXA, DDM Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Jun 06, 5:07AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Augusta Resource Corp (AMEX:AZC), Canlan Ice Sports Corp (NYSE:ICE), CurrencyShares Australian Dollar Trust (NYSE:FXA), ProShares Ultra Dow30 (NYSE

DM) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

ProShares Ultra Dow30 Up 38.1% Since SmarTrend Uptrend Call (DDM)
Comtex SmarTrend(R) - Wed Jun 05, 9:38AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEX

DM) on November 23rd, 2012 at $68.80. In approximately 6 months, ProShares Ultra Dow30 has returned 38.05% as of today's recent price of $94.98.

Uptrend Call Working As ProShares Ultra Dow30 Stock Rises 41.7% (DDM)
Comtex SmarTrend(R) - Wed May 29, 9:08AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEX

DM) on November 23rd, 2012 at $68.80. In approximately 6 months, ProShares Ultra Dow30 has returned 41.72% as of today's recent price of $97.50.

42.8% Return Seen to Date on SmarTrend ProShares Ultra Dow30 Call (DDM)
Comtex SmarTrend(R) - Tue May 21, 5:27PM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEX

DM) on November 23rd, 2012 at $68.80. In approximately 6 months, ProShares Ultra Dow30 has returned 42.85% as of today's recent price of $98.28.

Shares of DDM Up 35.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri May 03, 10:59AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEX

DM) on November 23rd, 2012 at $68.80. In approximately 5 months, ProShares Ultra Dow30 has returned 35.28% as of today's recent price of $93.07.

DTH, XKO, VSCP, LUNA, DDM, DLS Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Apr 29, 5:54AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of WisdomTree DEFA Equity Income Fund (NYSE

TH), Lehman ABS Corp (NYSE:XKO), VirtualScopics Inc (NASDAQ:VSCP), Luna Innovations Inc (NASDAQ:LUNA), ProShares Ultra Dow30 (NYSE

DM), WisdomTree International SmallCap Dividend Fund (NYSE

LS) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

ProShares Ultra Dow30 Shares Up 29.8% Since SmarTrend's Buy Recommendation (DDM)
Comtex SmarTrend(R) - Fri Apr 26, 9:36AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEX

DM) on November 23rd, 2012 at $68.80. In approximately 5 months, ProShares Ultra Dow30 has returned 29.82% as of today's recent price of $89.32.

ProShares Ultra Dow30 Has Returned 32.8% Since SmarTrend Recommendation (DDM)
Comtex SmarTrend(R) - Thu Apr 11, 4:46PM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEX

DM) on November 23rd, 2012 at $68.80. In approximately 5 months, ProShares Ultra Dow30 has returned 32.82% as of today's recent price of $91.38.

Shares of DDM Up 27.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 04, 11:03AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEX

DM) on November 23rd, 2012 at $68.80. In approximately 4 months, ProShares Ultra Dow30 has returned 27.75% as of today's recent price of $87.89.

SSO, MVV, DDM, SWHC, AYR, DVR Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Mar 29, 7:33AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Silver Standard Resources Inc (NYSE:SSO), ProShares Ultra MidCap400 (NYSE:MVV), ProShares Ultra Dow30 (NYSE

DM), SMITH & WESSON HOLDING CORPORATION (NASDAQ:SWHC), Aircastle Ltd (NYSE:AYR), Cal Dive International Inc (NYSE

VR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

ProShares Ultra Dow30 Has Returned 25.6% Since SmarTrend Recommendation (DDM)
Comtex SmarTrend(R) - Thu Mar 21, 9:32AM CDT
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEX

DM) on November 23rd, 2012 at $68.80. In approximately 4 months, ProShares Ultra Dow30 has returned 25.55% as of today's recent price of $86.38.

Uptrend Call Working As ProShares Ultra Dow30 Stock Rises 22.5% (DDM)
Comtex SmarTrend(R) - Wed Mar 06, 11:10AM CST
SmarTrend identified an Uptrend for ProShares Ultra Dow30 (AMEX

DM) on November 23rd, 2012 at $68.80. In approximately 3 months, ProShares Ultra Dow30 has returned 22.51% as of today's recent price of $84.29.

Should You Chase this Rally?
Chad Karnes - ETFG - Thu Jan 03, 11:25PM CST
The markets rallied over 4% on 12/31 and 1/2. Is now the time to chase this rally? We see many reasons to not trust this market's continued advance.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Chemours Faces Class Action Over Fraud Allegations

Chemours and the Aftermarket Mirage When it rains, it pours, and for Chemours, the forecast isn't looking sunny. Investors are gearing up to slap Chemours Company (NYSE: CC) with a securities fraud class action. Why, you ask? Overstatement of aftermarket demand for refrigerants left investors high and dry after stock prices took an 18% nosedive. On August 4, 2026,...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Stephen A. Smith Calls for Corporate Support of HBCUs

A Stand for Education at the White House Stephen A. Smith stirred the pot with his decision to attend a White House dinner, a move that had tongues wagging across the media landscape. But this time, it wasn't about the usual hustle and bustle of the sports world. Smith had his sights set on the big picture, specifically, the long-term financial stability of Historically...

York Space Systems Class Action: Deadline Approaches

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Gentex Shares Tumble Amid Legal Investigation Concerns

Gentex's Financial Outlook Takes a Hit Well, here we are again, catching another corporate hiccup. Gentex Corporation, or as ticker hounds know it, NASDAQ:GNTX, just pulled the rug out from its investors by chopping the top off its 2026 revenue guidance. Dropping to a floor it once considered a ceiling, $2.65 billion is now the most optimistic number they're pitching. No...

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....